Recently added items

New research suggests metformin is related to much less extreme COVID-19 throughout prediabetic people

In a latest research posted to the medRxiv* preprint server, researchers illustrated that metformin was related to decreased coronavirus illness 2019 (COVID-19) severity amongst prediabetic sufferers.

Research: Metformin is Related to Decreased COVID-19 Severity in Sufferers with Prediabetes. Picture Credit score: bangoland/Shutterstock


For the reason that graduation of the COVID-19 pandemic attributable to extreme acute respiratory syndrome coronavirus 2 (SARS-CoV-2), researchers and clinicians have strived for novel therapeutic prospects for managing COVID-19 sufferers. Current remedies, together with immune-related and antiviral therapies, have decreased however not fully eradicated SARS-CoV-2-linked mortality and morbidity. The continued SARS-CoV-2 pandemic emphasizes the essentiality of discovering medication that improve COVID-19 outcomes.

Drug repurposing is one technique for locating new medicines, and it entails figuring out priorly marketed medication that may be helpful in treating COVID-19. Proof means that an oral antihyperglycemic agent, metformin, is expounded to much less extreme SARS-CoV-2 an infection in diabetic sufferers relative to different antihyperglycemic medication.

Apparently, metformin is prescribed for off-label utilization in some individuals who don’t have diabetes, together with these with prediabetes and polycystic ovary syndrome (PCOS). These sufferers additionally belong to high-risk populations for extreme SARS-CoV-2 an infection. Therefore, these cohorts supply an opportunity to discover additional the affect of metformin use earlier than the event of COVID-19.

Concerning the research

Within the current retrospective observational evaluation, the investigators hypothesized that reported metformin utilization earlier than COVID-19 will likely be linked to diminished severity of SARS-CoV-2 an infection outcomes. In flip, metformin use earlier than an infection may be an economical technique for favorable COVID-19 outcomes for prediabetic sufferers via glycemic administration or different mechanisms.

The researchers constructed teams of SARS-CoV-2-positive non-diabetic metformin customers with both prediabetes or PCOS. Additionally they constructed propensity-weighted 282 and 313 levothyroxine management customers, a hypothyroidism medicine not recognized to affect COVID-19 outcomes, with PCOS and prediabetes, respectively. The scientists achieved this utilizing harmonized digital well being report (EHR) info from 53 hospitals. Intimately, they utilized scientific affected person knowledge from the Nationwide COVID Cohort Collaborative (N3C) in america (US).

Sufferers who examined constructive for SARS-CoV-2 after 1 January 2020, utilizing laboratory procedures similar to polymerase chain response (PCR) or antigen screening, had been included within the research. Additional, COVID-19-positive sufferers had been allotted to the PCOS and prediabetes affected person cohorts.

The crew explored the potential connection between metformin remedy and COVID-19 severity inside every cohort. Furthermore, the authors carried out inverse chance weighting to regulate additional the residual covariate mismatch throughout the teams. The first research consequence of curiosity was SARS-CoV-2 an infection severity, labeled as delicate emergency division (delicate ED), delicate, extreme, reasonable, or hospice/mortality. 


Cumulatively, the scientists discovered a big correlation between much less extreme COVID-19 and metformin use among the many prediabetes group relative to levothyroxine use adopting a binary categorization. The research outcomes demonstrated that metformin use was related to a diminished fee of SARS-CoV-2 infections among the many prediabetes cohort that had been delicate ED, delicate or worse, and reasonable or worse in severity. Therefore, the research knowledge confirmed the connection between metformin use and fewer extreme SARS-CoV-2 an infection.

Alternatively, the authors didn’t uncover any correlation between metformin use and COVID-19 severity amongst PCOS sufferers. Nevertheless, the variety of sufferers was comparatively restricted. This inference may point out that both the metformin-mediated discount in COVID-19 severity was not occurring in people with PCOS or that the facility of the research was inadequate to determine the metformin-mediated enchancment. 

Moreover, level estimations of the percentages ratio of metformin in comparison with levothyroxine had been directionally fixed in PCOS and prediabetic populations. Nevertheless, these associations weren’t statistically important.


Though there have been quite a few research to find out how metformin impacts COVID-19 in folks with sort 2 diabetes, the authors claimed that the current analysis was the broadest research to look into its off-label use, together with these with PCOS and prediabetes.

In response to the research findings, metformin, like in different research of folks with diabetes, was linked to much less extreme SARS-CoV-2 an infection in sufferers with prediabetes. This was a big discovering contemplating 19% to 38% of People have prediabetes, and COVID-19 continues to be a public well being disaster.

The crew talked about that the small variety of sufferers with probably the most extreme SARS-CoV-2 illness or infection-linked mortality prevented them from figuring out how a lot metformin reduces the chance of COVID-19-associated loss of life or mechanical air flow in prediabetic people. Future research using potential trials and presumably randomized investigations are required to outline the connection between COVID-19 severity and metformin in folks with prediabetes and to find out whether or not metformin is linked to raised SARS-CoV-2 an infection outcomes.

*Vital discover

medRxiv publishes preliminary scientific reviews that aren’t peer-reviewed and, subsequently, shouldn’t be considered conclusive, information scientific apply/health-related conduct, or handled as established info.

Journal reference:

Leave a Comment

Your email address will not be published.